Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.59NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LG.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.2.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.10NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LK.2.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LB.1.7.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.7.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KR.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-22381.5US
JN.1.15.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.15.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.50.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.50.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-4388.79US
LB.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LF.3.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.3.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.18.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.6NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.3.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.3.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.65.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.65.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LF.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.1.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XDVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDVNSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.100 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.100 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
AY.44 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.44 (Delta)NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.7NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LD.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KW.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.7.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KP.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used